— Fundamental Stock Analysis and Report Card
Located in Dublin, DU, IE. STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.
Revenue, earnings and profitability.
Strong revenue growth and earnings can attract investors, driving the stock price up. Profitability indicates the company's efficiency and sustainability, which impacts investor confidence. Poor performance in these areas can lead to a decrease in stock price.
Revenue History
Earnings History
Margins
Income & Cash Flow analysis.
An income statement shows what a company earned and spent over a period — revenue at the top, costs and expenses in between, and net income at the bottom. A cash flow statement tracks the actual cash moving in and out, across operations, investing, and financing. Read together, they show whether reported earnings are backed by real cash.
Q4 2026 Total ($) | Q4 2026 Margin (%) | |
|---|---|---|
| Revenue | 1.6b +107.9m +7.3% | |
| Gross Income | 697.1m +55.9m +8.7% | 44% +0.6pp +1.3% |
| EBITDA | 680.1m +343.3m +101.9% | 43% +20.1pp +88.2% |
| Operating Income | 316.8m +100.6m +46.6% | 20% +5.3pp +36.6% |
| Net Income | 220.3m +74.6m +51.2% | 14% +4.0pp +41.0% |
| Earnings Per Share | 2.24 +0.8 +51.4% | |
| Operating Cash Flow | 335.4m +74.6m +28.6% | 21% +3.5pp +19.9% |
| Free Cash Flow | 245.2m +55.3m +29.1% | 15% +2.6pp +20.4% |
| Research & Development | 28.8m +1.1m +4.0% | 2% -0.1pp -3.0% |